Exploring anthropometric and laboratory differences in children of varying ethnicities with celiac disease

Insights

South Asian children with celiac disease (CD) presented with more growth concerns and higher antibody levels than Caucasian children. Timely diagnosis and culturally tailored education are crucial for this growing population.

Area of Science:

  • Pediatric Gastroenterology
  • Autoimmune Disorders
  • Clinical Research

Background:

  • Celiac disease (CD) is a prevalent autoimmune disorder with rising incidence, particularly among ethnic minorities.
  • Understanding ethnic variations in CD presentation and diagnosis is crucial for equitable healthcare.

Purpose of the Study:

  • To investigate the frequency of CD diagnosis in ethnic minority children at a Canadian pediatric celiac clinic.
  • To identify ethnic differences in CD presentation, diagnosis, and follow-up outcomes.

Main Methods:

  • Retrospective analysis of 272 pediatric patients with biopsy-proven CD diagnosed between 2008-2011.
  • Data collected included demographics, ethnicity, symptoms, anthropometrics, and serum antitissue transglutaminase (aTTG) levels at diagnosis and 12-month follow-up.
  • Patients were categorized into Caucasian and other ethnicities, with a focus on South Asian children.

Main Results:

  • South Asian children (20% of cohort) presented more frequently with growth concerns (68% vs. 21%) and had higher diagnostic aTTG levels (834 IU/mL vs. 367 IU/mL) compared to Caucasian children.
  • While both groups showed symptom improvement, aTTG levels normalized by one year in significantly fewer South Asian children (29% vs. 64%).

Conclusions:

  • South Asian children represent a substantial proportion of pediatric CD cases in this Canadian clinic.
  • Ethnic disparities exist in CD presentation and diagnostic marker normalization, highlighting the need for targeted diagnostic and management strategies.
  • Culturally sensitive educational support is recommended for South Asian children with CD to improve follow-up outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K